Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 1b IMGN853 in Comb w/ Bevacizumab, Carboplatin or Pegylated Adv Epithelial Ovarian Ca

Protocol: OSU-15186

Full Title

A Phase Ib Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Mirvetuximab Soravtansine (IMGN853) in Combination with Bevacizumab, Carboplatin or Pegylated Liposomal Doxorubicin in Adults with Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, or Endometrial Cancer

Gynecologic Cancers Ovarian Cancer